1620 Investment Advisors »

Vertex Pharmaceuticals Incorporated shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $82k 176 464.84
2024-06-30 $79k 169 468.72

More positions owned by 1620 Investment Advisors

SPDR Portfolio Intrmdt Term Corp Bd ETF Etf (SPIB)
iShares 7-10 Year Treasury Bond ETF Etf (IEF)
SPDR MSCI EAFE StrategicFactors ETF Etf (QEFA)
SPDR S&P 600 Small Cap ETF Etf
Tri Continental Corporation Etf (TY)
SPDR Ptf Short-Term Treasury ETF Etf (SPTS)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
TJX Companies (TJX)
iShares Short Term Ntnl Muni Bond ETF Etf (SUB)
iShares Short-Term Corporate Bond ETF Etf (IGSB)
Microsoft Corporation (MSFT)
Freedom 100 Emerging Markets ETF Etf (FRDM)
Schwab U.S. TIPS ETF Etf (SCHP)
SPDR Doubleline Total Return Tactical ETF Etf (TOTL)

View all positions for 1620 Investment Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
Capital Research Global Investors
FMR
Jpmorgan Chase & Co
Wellington Management Company
Geode Capital Management
Jennison Associates
Alliancebernstein
Loomis, Sayles and
Norges Bank Investment Management
Amundi
Morgan Stanley

View all funds holding Vertex Pharmaceuticals Incorporated